Innovative Health Initiative (IHI) Joint Undertaking
The Innovative Health Initiative (IHI) Joint Undertaking is a public-private partnership between the EU and the pharmaceutical industry. It aims to translate scientific knowledge into safe and effective health innovations and to strengthen the competitiveness of European health industries.
Who is funded?
The IHI Joint Undertaking funds collaborative healthcare research projects. Target groups include organizations active in medical research and healthcare, with a focus on translating research results into concrete benefits for patients and society, and strengthening European health industries.
What is funded?
The IHI supports collaborative research projects that develop innovative approaches to medical research and healthcare. The focus is on cross-sectoral partnerships and addressing strategic, unmet public health needs.
Type and Scope of Funding
The IHI provides funding in the form of grants. The total contribution from the European Union amounts to up to 1.2 billion Euros, supplemented by at least the same amount from other members and contributing partners.
Conditions and Requirements
Participation in the IHI program is subject to certain conditions, including the formation of consortia, adherence to ethical principles, and ensuring access to results and products.
Application Procedure
The IHI application procedure is based on open calls published via the EU Funding & Tender Portal.
Legal Basis
The IHI Joint Undertaking was established by a specific EU regulation and is subject to the framework of the Horizon Europe program and other comprehensive regulations on funding and administration.
Similar Programs
Funding Overview
Funding Status:
Open
Allocated Budget:
Union: up to EUR 1,200,000,000 (of which up to EUR 30,212,000 for administrative costs). Other members: at least EUR 1,000,000,000 (of which up to EUR 30,212,000 for administrative costs).
Deadline:
always open
Open Until:
31.12.2031
Award Channel:
Framework Programme Call
Region:
European Union and associated Horizon Europe countries
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Service Sector
Beneficiaries:
Healthcare, medical research, pharmaceutical industry, patient organizations
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Market Introduction, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Union, European Federation of Pharmaceutical Industries and Associations (EFPIA), European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry (COCIR), EuropaBio, MedTech Europe, Vaccines Europe
Managed By:
Innovative Health Initiative (IHI) Joint Undertaking